The use of rIX-FP in patients with haemophilia B: a nurse's perspective

The use of rIX-FP in patients with haemophilia B: a nurse's perspective

The management of patients with haemophilia is complex and requires lifelong care to be delivered by a specialist multidisciplinary team. Haemophilia B results from a deficiency or absence in coagulation factor IX (FIX), leading to easy bruising, and musculoskeletal and internal bleeding. For patien...

Full description

Bibliographic Details
Main Authors:	Garner Kara, Guelcher Christine, Pollard Debra
Format:	Article
Language:	English
Published:	Sciendo 2021-08-01
Series:	The Journal of Haemophilia Practice
Subjects:	factor ix haemophilia b pharmacokinetics prophylaxis rix-fp nurse
Online Access:	https://doi.org/10.17225/jhp00180

Similar Items

Benefits of rIX-FP prophylaxis in patients with Haemophilia B: real-world evidence from a Spanish reference centre
by: Olga Benítez-Hidalgo, et al.
Published: (2023-12-01)

Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID‐19 pandemic
by: Bolívar Luis Díaz‐Jordán, et al.
Published: (2023-12-01)

Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX‐FP): A case report
by: Francisco José López‐Jaime, et al.
Published: (2023-06-01)

Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials
by: Astermark J, et al.
Published: (2021-07-01)

Haemophilia specialist nurses’ perceptions of haemophilia B
by: Chaplin Steve, et al.
Published: (2021-10-01)

Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B
by: Richard Lemons, et al.
Published: (2024-01-01)

"Relation of Factor VIII and IX Inhibitors with ABO Blood Groups in 150 Patients with Haemophilia A and B "
by: Hassan Mansouri Torghabeh, et al.
Published: (2006-03-01)

MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
by: Maimiza Zahari, et al.
Published: (2018-09-01)

Living, Caring, Learning - Changing mindsets and enabling goals for people with haemophilia
by: Cruickshank Anne-Louise
Published: (2024-02-01)

Web-based Application for the Population Pharmacokinetic Service (WAPPS)'s impact on dosage selection: a single paediatric centre experience
by: Kwan Celia, et al.
Published: (2021-07-01)

European principles of inhibitor management in patients with haemophilia
by: P. L. F. Giangrande, et al.
Published: (2018-04-01)

Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update
by: Andrea Aiello, et al.
Published: (2022-01-01)

Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation
by: Dorina Cultrera, et al.
Published: (2022-07-01)

Experience of switching to NovoEight: views of people with haemophilia
by: Pollard Debra, et al.
Published: (2020-06-01)

European principles of inhibitor management in patients with haemophilia: implications of new treatment options
by: C. Hermans, et al.
Published: (2020-08-01)

Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe
by: Tom Burke, et al.
Published: (2021-12-01)

How to Manage a Patient with Haemophilia and ACS Requiring PCI: A Battle between Bleeding and Thrombosis
by: Konstantinos C. Theodoropoulos, et al.
Published: (2021-04-01)

High-transmission spectrometer for rapid resonant inelastic soft X-ray scattering (rRIXS) maps
by: Lothar Weinhardt, et al.
Published: (2024-11-01)

The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng
by: Lethukuthula Mafisa, et al.
Published: (2022-10-01)

Predictors of treatment adherence in patients with chronic disease using the Multidimensional Adherence Model: unique considerations for patients with haemophilia
by: Strike Karen, et al.
Published: (2020-07-01)

Three-Decade Successive Establishment of Care for Women/Girls from Families with Haemophilia
by: Chuansumrit A, et al.
Published: (2022-10-01)

The patient gene therapy journey: Findings from qualitative interviews with trial participants at one UK haemophilia centre
by: Aradom Elsa, et al.
Published: (2021-05-01)

Adherence to prophylaxis in adolescents and young adults with severe haemophilia: a qualitative study with healthcare professionals
by: S. van Os, et al.
Published: (2020-01-01)

The Heisenberg-RIXS instrument at the European XFEL
by: Justine Schlappa, et al.
Published: (2025-01-01)

Recognising the importance of the research nurse and study coordinators in enhancing retention of people with haemophilia in clinical trials
by: Khair Kate, et al.
Published: (2023-12-01)

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B
by: Andrea Aiello, et al.
Published: (2020-07-01)

Personalised Prophylaxis in a Child with Haemophilia A and Type 1 Diabetes
by: Maria Sol Cruz, et al.
Published: (2021-05-01)

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies
by: David M. Markusic, et al.
Published: (2013-09-01)

Acquired Haemophilia Associated with Urticarial Vasculitis
by: Hassene Attout
Published: (2020-05-01)

Anaesthetic management of a patient with haemophilia
by: Prashanth Mallya, et al.
Published: (2007-01-01)

Switching factor products: nurses’ experience with NovoEight
by: Pollard Debra, et al.
Published: (2020-06-01)

Pattern of Haemarthrosis in Haemophilia
by: Zahida Qasim
Published: (2013-12-01)

Comparison of joint status using ultrasound assessments and Haemophilia Joint Health Score 2.1 in children with haemophilia
by: Yanju Li, et al.
Published: (2023-07-01)

Factor VIII delivery devices in haemophilia A. Barriers and drivers for treatment adherence
by: Isabel Fernández-Arias, et al.
Published: (2016-12-01)

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
by: Tine M.H.J. Goedhart, et al.
Published: (2022-01-01)

Living, Caring, Learning - Building family relationships in haemophilia care
by: Shoemark Robyn
Published: (2024-02-01)

Theory of Spin-Excitation Anisotropy in the Nematic Phase of FeSe Obtained From RIXS Measurements
by: Andreas Kreisel, et al.
Published: (2022-04-01)

Living, Caring, Learning – Collaborating across borders to support a haemophilia patient with a rare complication
by: Githinji Cyrus
Published: (2024-05-01)

Processes and experiences of satellite haemophilia clinic set-ups in Uganda – a short report
by: Kasirye Philip, et al.
Published: (2022-05-01)

Educational needs of patients, families, and healthcare professionals to support the patient journey in haemophilia gene therapy in the UK
by: Sara Boyce, et al.
Published: (2023-11-01)